Patent application number | Description | Published |
20110294897 | Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion - Methods for the treatment of patients suffering from dry eyes, by using adrenergic beta-receptor agonists, particularly salbutamol and in particular the optically pure or substantially pure R-enantiomer thereof. The embodiments disclosed herein include methods of increasing the Meibomian lipid secretion and thereby reducing or eliminating xerophthalmia symptoms by the administration of formulations containing therapeutically effective amounts of an adrenergic beta-receptor agonist to said patients. In particular, certain embodiments disclosed herein concern compositions that contain R-salbutamol as the active beta-receptor stimulating ingredient. In certain embodiments, the formulations are administered to the ocular surface of the eye and/or to the eyelid (the underside of the eyelid and/or the top of the eyelid) of a patient in need thereof. | 12-01-2011 |
20140113936 | MEDICINAL TREATMENT OF DERMAL DISEASES IN COMPANION ANIMALS - The methods disclosed herein relate to the treatment of skin infections in dogs, by-administering a therapeutically effective amount of norketotifen. Therapeutic antimicrobial activity of norketotifen against | 04-24-2014 |
20140120121 | MEDICINAL TREATMENT OF ATOPIC INFLAMMATORY DISEASES - The methods disclosed herein relate to the treatment of atopic inflammatory disorders, such as dermal or pulmonary atopic inflammatory disorders, in humans, by administering a therapeutically effective amount of ractopamine. | 05-01-2014 |
20150045392 | METHODS OF TREATING PRURITIC CONDITIONS MEDIATED THROUGH HISTAMINE H-4 RECEPTORS - The methods disclosed herein relate to the treatment of histamine H-4—related pruritus, by administering a histamine H-4 receptor inverse agonist that selectively accumulates at the biophases of the disorders, specifically RS-norketotifen or a pharmaceutically acceptable salt thereof. Potentiated antipruritic activity by simultaneous inhibition of histamine H-1 receptors and histamine H-4 receptors are described. | 02-12-2015 |
Patent application number | Description | Published |
20090302840 | METHOD AND APPARATUS FOR CONTRAST INFLOW DYNAMIC MR ANGIOGRAPHY - A system and method for MR imaging includes a computer programmed to determine first and second view-ordering sequences. The first and second view-ordering sequences comprise values corresponding to respective views of first and second k-space data sets, respectively, wherein the values corresponding to a central view of each the first and second k-space data sets are positioned such that acquisition of k-space data in each central view is acquired from a first and second anatomical region, respectively, as a contrast agent passes therethrough. The positions of the values corresponding to the central views of the first and second k-space data sets within the respective sequences are different. The computer is further programmed to acquire MR data according to the first and second view-ordering sequences over a series of cardiac cycles to fill data in the first and second k-space data sets, respectively. | 12-10-2009 |
20100245360 | SYSTEM AND METHOD FOR CENTER POINT TRAJECTORY MAPPING - A system and method for center point trajectory mapping includes a computer readable storage medium having stored thereon a computer program comprises instructions, which when executed by a computer, cause the computer to acquire a first plurality of images, each image comprising a masked portion. The instructions also cause the computer to locate a center point of the masked portion in each of the plurality of images and to plot a map based on variances in position of the center points from each other. The instructions further cause the computer to display the map on a display. | 09-30-2010 |
20110075902 | SYSTEM AND METHOD FOR MULTI-SEGMENT CENTER POINT TRAJECTORY MAPPING - A computer implemented method of mapping of multiple regional center point trajectory movements of cavity walls is provided in which images are acquired and a region-of-interest is identified in each of the images. The region-of-interest is divided into a plurality of distinct regions and a regional center point for each of the regions is located in the images. For each regional center point, a center point trajectory is determined based on variances in position of the center points from each other in the images. The center point trajectory of each regional center point is decomposed into radial and circumferential components so as to isolate radial component of the center point trajectory for each regional center point in each of the images and radial motion versus time curves are displayed for each regional center point based on the determined radial component for each regional center point in each of the images. | 03-31-2011 |
20120008833 | SYSTEM AND METHOD FOR CENTER CURVE DISPLACEMENT MAPPING - A system and method for center point trajectory mapping includes a computer readable storage medium having stored thereon a computer program comprises instructions, which when executed by a computer, cause the computer to obtain a first plurality of images, each image comprising an unmasked portion and a masked portion, and to calculate a center curve in the unmasked portion in each of the first plurality of images. The instructions further cause the computer to calculate a displacement of the center curve in each of the first plurality of images from a reference center curve, plot a map based on the calculated displacements, and display the map on a display. | 01-12-2012 |
20130281829 | SYSTEMS AND METHODS FOR MAGNETIC RESONANCE ANGIOGRAPHY - Systems and methods for Magnetic Resonance Angiography (MRI) are provided. One method includes obtaining Magnetic Resonance (MR) velocity data and determining a distance map for one or more vessels to define a distance path. The method also includes calculating, using the MR velocity data, at a plurality of time intervals and for a plurality of pixels (i) a distance traveled during a current time interval as a current distance traveled, wherein a total distance traveled is incremented by the current distance traveled and (ii) a bolus signal using a bolus signal profile, the distance path and total distance traveled, wherein a current time interval is incremented by a defined time step. | 10-24-2013 |
Patent application number | Description | Published |
20090090410 | Nanoengineered biophotonic hybrid device - An improved method for the design and development of high performance hybrid devices having biological and nonbiological components. The biological component is used in hybrid constructs that may be nanostructures, given the small size of the biological parts. In one specific embodiment, chlorosomes of | 04-09-2009 |
20100233748 | Device with biological component and method of making to achieve a desired transfer function - An improved method for the design and development of high performance hybrid devices having biologically-derived and nonbiological components and the hybrid devices so-designed and developed. A desired transfer function is determined for the biologically-derived component or components. The organism from which the biologically-derived component is derived is subjected to various environmental variables as it is grown. Organisms providing biologically-derived components having the desired transfer function are identified. The biologically-derived component is thereafter developed from organisms force adapted to cause the biologically-derived component transfer function to reach a goal or an acceptable measure. The biological component is used in hybrid constructs that may be nanostructures, given the small size of the biological parts. In one specific embodiment, force-adapted chlorosomes of | 09-16-2010 |
20100233749 | Device with biological component and method of making to achieve a desired figure of merit - An improved method for the design and development of high performance hybrid devices having biologically-derived and nonbiological components and the hybrid devices so-designed and developed. A desired figure of merit is determined for the biologically-derived component or components. The organism from which the biologically-derived component is derived is subjected to various environmental variables as it is grown. Organisms providing biologically-derived components having the desired figure of merit are identified. The biologically-derived component is thereafter developed from organisms force adapted to cause the biologically-derived component figure of merit to reach a goal or an acceptable measure. The biological component is used in hybrid constructs that may be nanostructures, given the small size of the biological parts. In one specific embodiment, force-adapted chlorosomes of | 09-16-2010 |
20100240020 | Method of making biological components for devices by forced environmental adaptation - An improved method for the design and development of high performance biologically-derived components for use in hybrid devices. The biologically-derived component is used in hybrid constructs that may be nanostructures, given the small size of the biological parts. Force adaptation is used to bring an organism from which the biologically-derived component is developed to provide such a component meeting a desired measure of performance. In one specific embodiment, chlorosomes of | 09-23-2010 |
20130119499 | Nanoengineered Biophotonic Hybrid Device - Apparatus, compositions, methods, and articles of manufacture are disclosed relating to the design and production of biological components and/or their incorporation in devices and systems, including biohybrid photosensitive devices and systems. In some embodiments, biological components include light antenna structures that collect light and emit Stokes-shifted light to a photoactive non-biological component. In some embodiments, the characteristics of biological components are engineered via force-adaptation of an organism or adaptive system. In some embodiments, biological components are modified by removing reaction centers or other structure not contributing to desired performance. | 05-16-2013 |